Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,001 public trials 2,038 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Active, not recruiting

A Phase 3 Trial of Epcoritamab vs Investigator's Choice Chemotherapy in Relapsed/Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL)

NCT04628494

Conditions
Diffuse Large B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Indiana Blood and Marrow Transplantation Indianapolis, Indiana, United States
  • Community Health Network Cancer Center North Indianapolis, Indiana, United States
  • University of Kentucky Markey Cancer Center Lexington, Kentucky, United States
  • Henry Ford Health System Jackson, Michigan, United States
View all 186 locations
View Trial Details
Active, not recruiting

A Study of Real Life Treatment for Multiple Myeloma (MM)

NCT04985643

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Altai Regional Clinical Hospital Barnaul, Altayskiy Kray, Russia
  • Kaluga Regional Clinical Hospital Kaluga, Central Federal District, Russia
  • Smolensk Clinical Hospital of Russian Railways-Medicine Smolensk, Central Federal District, Russia
  • City Clinical Hospital No. 1 named after prof. S.I.Sergeev Khabarovsk, Far Eastern Federal District, Russia
View all 24 locations
View Trial Details
Active, not recruiting

Phase 0 Master Protocol for CIVO Intratumoral Microdosing of Anti-Cancer Therapies

NCT04541108

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +23 more
Locations
  • LSU Health Sciences Center - Shreveport Shreveport, Louisiana, United States
  • Montefiore Medical Center The Bronx, New York, United States
  • University of North Carolina Chapel Hill, North Carolina, United States
  • UC Health Cincinnati, Ohio, United States
View Trial Details
Active, not recruiting

Study of Ibrutinib + CD20 Antibody and Venetoclax in Patients With Untreated Mantle Cell Lymphoma

NCT04802590

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • A.Z. Sint Jan AV Bruges, Belgium
  • Universite Libre de Bruxelles - Hopital ERASME Brussels, Belgium
  • Hopital Jolimont Haine-Saint-Paul, Belgium
  • CHU de Liege Liège, Belgium
View all 45 locations
View Trial Details

Related conditions